Our Recommendations
- Mejores prácticas para la atención de pacientes con tuberculosis (2017)
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update (2016)
- IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of illnesses with limited-resources. Vol. 2 (2011)
- Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice (2019)
- Field Guide for the Management of Drug-Resistant Tuberculosis (2018)
New Publications
- Framework for an Integrated Multisectoral Response to TB, HIV, STIS and Hepatitis in the WHO African Region 2021–2030 (2024)
- The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual (2023)
- TB Toolbox (2022)
- Manual operativo de la OMS sobre la tuberculosis. Módulo 1: Prevención. Tratamiento preventivo de la tuberculosis (2020)
- Lignes directrices unifiées de l’OMS sur la tuberculose : module 2 : dépistage: dépistage systématique de la tuberculose (2022)
Filter
111
Featured
Recommendations
21
New Publications
29
Language
Document type
No document type
63
Guidelines
24
Manuals
9
Training Material
6
Studies & Reports
3
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Videos
1
Countries / Regions
Russia
4
Ukraine
2
Global
2
India
2
Nepal
1
Colombia
1
Kenya
1
Chile
1
Afghanistan
1
Asia
1
South–East Asia Region
1
Bangladesh
1
South Africa
1
Eastern Europe
1
Brazil
1
Sri Lanka
1
Bhutan
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Toolboxes
TB
81
Caregiver
6
HIV
5
Refugee
4
Ebola & Marburg
3
Summary of current WHO recommendations and guidance on programmatic approaches
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
A survival guide for clinicans.
3rd edition.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
The SAARC Member States have more than an estimated 2.0 million TB cases accounting for close to one-third of the total cases of TB in the world. India alone had almost one-fifth of the global disease burden due to TB. India, Pakistan and Bangladesh followed by Afghanistan are the major contributors...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...
This interactive website provides detailed information on current and past BCG policies and practices for over 180 countries. The Atlas is designed to be a useful resource for clinicians, policymakers and researchers alike, providing information that may be helpful for better interpretation of TB di...
Руководство по ведению пациентов с латентной туберкулезной инфекцией
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
